SCHEMBL30406771

SCHEMBL30406771

c1cnc2cc(-c3c[nH]c4nc(CC5CCC5)ncc34)ccc2n1

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ DYRK1A Q13627 6/20 0.38
▸ CLK2 P49760 1/20 0.38
▸ CLK3 P49761 1/20 0.38
▸ PIM1 P11309 1/20 0.37
▸ PIM3 Q86V86 1/20 0.37
▸ PIM2 Q9P1W9 1/20 0.37
▸ DYRK1B Q9Y463 2/20 0.37
▸ CAMKK2 Q96RR4 4/20 0.35
▸ CAMKK1 Q8N5S9 2/20 0.35
▸ BRD4 O60885 3/20 0.35
▸ TDO2 P48775 3/20 0.34
▸ AAK1 Q2M2I8 1/20 0.34
▸ SGK1 O00141 1/20 0.34
▸ AURKA O14965 1/20 0.34
▸ SGK3 Q96BR1 1/20 0.34
▸ SGK2 Q9HBY8 1/20 0.34
▸ CDC7 O00311 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25519884 1.00 DYRK1A (0.38) DYRK1ACLK2CLK3PIM1PIM3
SCHEMBL30407715 0.89 DYRK1A (0.50) DYRK1ACLK2CLK3DYRK1BCAMKK2
SCHEMBL25519828 0.89 DYRK1A (0.50) DYRK1ACLK2CLK3DYRK1BCAMKK2
SCHEMBL25519953 0.84 TDO2 (0.51) DYRK1ACLK2CLK3CAMKK2CAMKK1
SCHEMBL26175933 0.83 DYRK1B (0.38) DYRK1APIM1PIM3PIM2DYRK1B
SCHEMBL30346921 0.82 ACP1 (0.41) DYRK1ACLK2CLK3CAMKK2BRD4
SCHEMBL25518054 0.82 ACP1 (0.41) DYRK1ACLK2CLK3CAMKK2BRD4
SCHEMBL25157721 0.81 TDO2 (0.45) DYRK1ACLK2CLK3DYRK1BTDO2
SCHEMBL30406687 0.81 TDO2 (0.45) DYRK1ACLK2CLK3DYRK1BTDO2
SCHEMBL30406815 0.81 CAMKK2 (0.39) DYRK1ACLK2CLK3PIM1PIM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167133-A1 7H-PYRROLO[2,3-D]PYRIMIDINES AND PREPARATION AND USES THEREOF VICKERS VENTURE FUND VI PTE. LTD. (SG) 2023-06-01 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167133-A1 7H-PYRROLO[2,3-D]PYRIMIDINES AND PREPARATION AND USES THEREOF DYRK1A, DYRK1B, DYRK2 DYRK1A 1/4885CLK2 466/4885CLK3 1147/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback